Fennec Pharmaceuticals (FENC) Exchange Rate Effect (2011)
Fennec Pharmaceuticals posted quarterly Exchange Rate Effect of -$110000.0 for Q4 2011, down 478.95% on a QoQ basis from -$19000.0 in Q3 2011.
Fennec Pharmaceuticals (FENC) has 1 years of Exchange Rate Effect data on file, last reported at -$110000.0 in Q4 2011.
- For the quarter ending Q4 2011, Exchange Rate Effect changed N/A year-over-year to -$110000.0; the trailing twelve-month figure through Sep 2012 stood at -$110000.0 (down 104.71% YoY), and the FY2011 full-year result was $10000.0, changed N/A from the prior year.
- Exchange Rate Effect for Q4 2011 stood at -$110000.0, down from -$19000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $124000.0 in Q1 2011 and bottomed at -$110000.0 in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -110,000.00 |
| Dec 31, 2011 | -110,000.00 |
| Sep 30, 2011 | -19,000.00 |
| Sep 30, 2011 | -19,000.00 |
| Jun 30, 2011 | 15,000.00 |
| Jun 30, 2011 | 15,000.00 |
| Mar 31, 2011 | 124,000.00 |
| Mar 31, 2011 | 124,000.00 |